Pharmacokinetics and Pharmacodynamics (Training Workshop)



This two-day workshop provides an introduction to the the primary elements of pharmacokinetics and pharmacodynamics, whilst giving you an opportunity to get hands on experience with analysis, modelling and simulation during the tutorials.

Save up to 25% with our early bird offer - ends 27 April 2023.

This popular training workshop covers the fundamental aspects of pharmacokinetics and pharmacodynamics. This two-day event takes the format of lectures introducing concept, basic theory and practical examples reinforced with data analysis and modelling and simulation. Delegates will be expected to play an active role in analysis, interpretations and discussion. 

Learning Outcomes:
  1. To introduce the fundamental principles of pharmacokinetic (PK) and pharmacodynamic (PD) data analysis
  2. To consider other contributory factors and processes that influence PK and PD measurements and outcomes
  3. To appreciate and understand the importance and contribution of PK/PD by first intent to inform preclinical and clinical study design

This workshop is also supported by virtual pre-learning that will be circulated to registrants

If you have any questions, please do not hesitate to contact the Education team (education@bps.ac.uk / +44 20 7239 0170).


You can view and download a PDF copy of the programme

Thursday 8 June 2023

Registration and refreshments 11:00 - 11:30

Introduction to the PKPD Workshop 11:30 -11:45

Kevin Smart, Director, Clinical Pharmacology and Pharmacometrics at AstraZeneca

Basic Pharmacokinetic Concepts 11:45 - 12:45

Kevin Smart, Director, Clinical Pharmacology and Pharmacometrics at AstraZeneca

Lunch and networking 12:45 - 13:45

Tutorial on Pharmacokinetics Data Analysis (Part 1) 13:45 - 14:45

Tutorial on Pharmacokinetics Data Analysis (Part 2) 14:45 - 15:45

Factors affecting pharmacokinetics 15:45 - 16:45

James Clarke, Clinical Science Leader in Oncology at GlaxoSmithKline

Optional Workshop Dinner 18:30 - 20:30
This dinner is an opportunity to interact and network further with the trainers and other workshop attendees

Friday 9 June 2023

Refreshments 08:40 - 09:00

Tutorial on Pharmacokinetic Modelling 09:00 - 10:00
Kevin Smart, Director, Clinical Pharmacology and Pharmacometrics at AstraZeneca

Introduction to Pharmacokinetic-Pharmacodynamic Modelling 10:00 - 11:00
Pinky Dua, Head of Quantitative Clinical Pharmacology at UCB

Refreshments and networking 11:00 - 11:15

Tutorial on Pharmacokinetic-Pharmacodynamic Modelling 11:15 - 12:15
Rob Willis, Principle Scientist at Merck Sharp & Dohme
Kevin Smart, Director, Clinical Pharmacology and Pharmacometrics at AstraZeneca

Integration of Pharmacokinetics and Pharmacodynamics in Pre-Clinical Drug Discovery 12:15 - 13:15
Rob Willis, Principle Scientist at Merck Sharp & Dohme 

Lunch and networking 13:15 - 14:15

Integration of Pharmacokinetics and Pharmacodynamics in Clinical Pharmacology 14:15 - 15:15
Pinky Dua, Head of Quantitative Clinical Pharmacology at UCB

Wrap up and Discussion 15:15 - 15:30

You can view and download a PDF copy of the programme


You can view and download a copy of the speaker biographies here. 

Dr Rob Willis
Rob Willis BSc, PhD is currently Principal Scientist, Pharmacokinetics at MSD providing strategic DMPK input as part of a multi-functional lead optimisation drug discovery programme team.
In his role, Rob is responsible for the design and implementation of key DMPK and in vivo efficacy studies to evaluate molecules from start of chemistry through lead optimisation to candidate selection. He has previously worked at GSK and Heptares with over 15 years’ experience providing DMPK input to early-stage discovery programmes across a number of therapy areas. He is experienced in PK, PK/PD and PBPK modelling including human PK and efficacious dose predictions from preclinical data. Rob has recently completed his PhD investigating PK/PD modelling of acute inflammatory challenge models.

James Clarke
James holds an MSc in Biochemistry from the University of Kent. James has over two decades postgraduate experience in the pharmaceutical industry across multiple disease areas within Pfizer, AstraZeneca, Shire, BTG and more recently GSK. In the past, James has held roles in drug target validation, DMPK and clinical pharmacology. In his current role as a Director of Clinical Sciences James oversees clinical trail/programme design and execution for first time in human to proof of concept clinical studies in oncology.

Dr Pinky Dua
Pinky Dua is Head of Qualitative Clinical Pharmacology at UCB. Pinky has over 15 years' experience in the pharmaceutical industry and has a strong scientific and technical background with a proven track record in quantitative modelling and simulation for drug discovery and development. Pinky has worked across a wide variety of therapeutic areas - Pain, Neurology, Psychiatry, Respiratory, GI and Rare Diseases. Pinky had a PhD in Chemical Engineering from Imperial College London, and has published over 20 journal and conference papers and 6 book chapters. Pinky has delivered invited/plenary talks at international pharmaceutical conferences and at academic institutions.

Dr Kevin Smart
Kevin Smart, BSc, PhD is currently a Director of Pharmacology and Pharmacometrics at AstraZeneca, with over 20 years' experience in the pharmaceutical industry. Kevin has worked across all areas of pharmacology drug development including pre-clinical DMPK, Clinical Pharmacology and now Pharmacometrics, in therapy areas ranging from Neurology, Psychiatry, GI, Respiratory and Oncology.
 
​

Tickets

Member Registration Member Ticket £305.00
Non-Member Registration Non-Member Ticket £395.00
From
08 June 2023
To
09 June 2023
Time
11am BST to 3.30pm BST
Delivery Method
In-Person Only
Venue
1 Naoroji Street, London WC1X 0GB

Contact

About this website

Join the conversation

BPS Assessment Ltd

Connect with us:

© 2021 British Pharmacological Society, The Schild Plot, 16 Angel Gate, City Road, London EC1V 2PT, United Kingdom

loading